Search research articles
Contact Us
Filters
Showing results (941-950 of 962) with videos related to
Page
of 97
Sort By:
The New England Journal of Medicine
|
April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
C Michael Gibson, Danielle Duffy, Serge Korjian, et al.
American Heart Journal
|
February 12, 2022
Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial
Mandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
The New England Journal of Medicine
|
April 8, 2024
Empagliflozin after Acute Myocardial Infarction
Javed Butler, W Schuyler Jones, Jacob A Udell, et al.
European Heart Journal
|
June 5, 2026
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model
Joris Holtrop, Mari N Gynnild, Salil V Deo, et al.
Journal of the American College of Cardiology
|
April 8, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
Jacob A Udell, Mark C Petrie, W Schuyler Jones, et al.
Circulation. Cardiovascular Interventions
|
December 17, 2024
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial
Harmony R Reynolds, Courtney B Page, Leslee J Shaw, et al.
Critical Care Explorations
|
November 13, 2023
Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis
Patrick R Lawler, Garen Manvelian, Alida Coppi, et al.
Circulation
|
April 6, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial
Adrian F Hernandez, Jacob A Udell, W Schuyler Jones, et al.
Circulation
|
June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium
Davide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.
Journal of the American College of Cardiology
|
April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
Thomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
Page
of 97
Search research articles
Search
Showing results (941-950 of 962) with videos related to
Sort By:
Page
of 97
The New England Journal of Medicine
|
April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
C Michael Gibson, Danielle Duffy, Serge Korjian, et al.
American Heart Journal
|
February 12, 2022
Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial
Mandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
The New England Journal of Medicine
|
April 8, 2024
Empagliflozin after Acute Myocardial Infarction
Javed Butler, W Schuyler Jones, Jacob A Udell, et al.
European Heart Journal
|
June 5, 2026
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model
Joris Holtrop, Mari N Gynnild, Salil V Deo, et al.
Journal of the American College of Cardiology
|
April 8, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
Jacob A Udell, Mark C Petrie, W Schuyler Jones, et al.
Circulation. Cardiovascular Interventions
|
December 17, 2024
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial
Harmony R Reynolds, Courtney B Page, Leslee J Shaw, et al.
Critical Care Explorations
|
November 13, 2023
Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis
Patrick R Lawler, Garen Manvelian, Alida Coppi, et al.
Circulation
|
April 6, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial
Adrian F Hernandez, Jacob A Udell, W Schuyler Jones, et al.
Circulation
|
June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium
Davide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.
Journal of the American College of Cardiology
|
April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
Thomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
Page
of 97